New Paradigms in the Novel Neuromodulation-Based Therapies for Dry Eye Disease
Complimentary
Enduring Webcast
Released on 5/6/26
Expires on 5/6/27
Program Description
This enduring webcast will provide up-to-date, evidence-based information on novel neuromodulation-based therapies for Dry Eye Disease (DED).
Intended Audience
This activity is designed to meet the educational needs of ophthalmologists, optometrists, advanced practice providers (physician assistants and nurse practitioners), and nurses who manage patients with dry eye disease (DED).
Commercial Supporter
Supported by an unrestricted educational grant from Alcon Vision, LLC.
Learning Objectives
After completing this activity, the participant should be better able to:
- Integrate the factors contributing to DED, such as the lacrimal functional unit and TRPM8 channels, which regulate basal tear secretion.
- Implement novel neuromodulation-based therapies to improve patient outcomes of individuals with DED.
Accredited Providers
Jointly Accredited by Amedco and MedNet
This activity is jointly provided by Amedco and MedNet.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco and MedNet. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME) Credit Designation
Amedco designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
PAs may claim a maximum of 1.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allows reciprocity for AANPCP continuing education credit. 1.25 hours.
Faculty

Anat Galor, MD, MSPH
Professor of Ophthalmology, Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FL
Dr. Galor discloses the following:
Consultant: Alcon, Amgen, Bausch + Lomb, Dompé, EyeCool, Genentech, Novartis, and OKYO

Beeran Meghpara, MD
Director of Refractive Surgery
Co-Chief of the Cornea Service
Wills Eye Hospital
Philadelphia, PA
Dr. Meghpara discloses the following:
Consultant: Alcon, Allergan, Bausch & Lomb, BioTissue, Dompé, Glaukos, Johnson & Johnson Vision, Orasis, RxSight, Sight Sciences, Sun, Tarsus, W. L. Gore & Associates, and Zeiss
Speaker: Alcon, Dompé, Johnson & Johnson Vision, and Sun
All relevant financial relationships for these individuals have been mitigated.
Instructions
In order to receive CME/CE credits, participants must complete the pre-assessment questions, post-assessment, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript, which you can access at any time.
Related products
-

Emerging Strategies in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
Read more -

Sustained-Release Drug Delivery System in the Management of Glaucoma
Read more -

New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Read more -

Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes
Read more




